<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5705067</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.1002462</article-id><article-id pub-id-type="publisher-id">PMEDICINE-D-17-03755</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>HIV epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>HIV diagnosis and management</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Russia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Europe</subject><subj-group><subject>Russia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>AIDS</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Public and occupational health</subject><subj-group><subject>Preventive medicine</subject><subj-group><subject>HIV prevention</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The expanding epidemic of HIV-1 in the Russian Federation</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0665-9124</contrib-id><name><surname>Beyrer</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Wirtz</surname><given-names>Andrea L.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>O&#x02019;Hara</surname><given-names>George</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>L&#x000e9;on</surname><given-names>Nolwenn</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kazatchkine</surname><given-names>Michel</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Haverford College, Haverford, Pennsylvania, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Office of the UN Secretary-General&#x02019;s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva, Switzerland</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Global Health Center, the Graduate Institute of International and Development Studies, Geneva, Switzerland</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>We have read the journal's policy and the authors of this manuscript have the following competing interests: CB is a member of the Editorial Board of <italic>PLOS Medicine</italic>. MK is the United Nations Special Envoy on HIV/AIDS in Eastern Europe and Central Asia. NL works at the Office of the UN Secretary General Special Envoy on HIV/AIDS in Eastern Europe and Central Asia.</p></fn><corresp id="cor001">* E-mail: <email>cbeyrer@jhu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2017</year></pub-date><volume>14</volume><issue>11</issue><elocation-id>e1002462</elocation-id><permissions><copyright-statement>&#x000a9; 2017 Beyrer et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Beyrer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pmed.1002462.pdf"/><abstract abstract-type="toc"><p>In a Perspective, Chris Beyrer and coauthors discuss the threat of HIV to health in the Russian Federation.</p></abstract><funding-group><funding-statement>This research was supported in part by the Desmond M. Tutu Professorship in Public Health and Human Rights at Johns Hopkins University. This research has also been facilitated by the infrastructure and resources provided by the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="6"/></counts></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>In 2017, the Russian Federation (RF) is estimated to have the largest number of HIV-1 infected citizens of any country in Europe [<xref rid="pmed.1002462.ref001" ref-type="bibr">1</xref>]. Cumulative reported diagnoses reached over 1.16 million infections by mid-2017, and actual infections, including those that remain undiagnosed and/or unreported, are doubtless substantially higher [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>]. In contrast to the global epidemic pattern, the HIV epidemic in the RF and in most countries of Eastern Europe and Central Asia continues to expand significantly. Over 103,000 new HIV diagnoses were reported in the RF in 2016, a 5% increase in new infections over the previous year [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>]; reported HIV diagnoses had been increasing at some 10% per year from 2011&#x02013;2016 [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>]. Among Russian men aged 30&#x02013;39 years of age, a group that has the highest male infection burden, some 2.8% were living with HIV infection in 2016 [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>]. AIDS deaths, too, are rising and now negatively impact life expectancy [<xref rid="pmed.1002462.ref003" ref-type="bibr">3</xref>]. From January to June 2017, some 14,631 AIDS deaths were recorded, a 13.5% increase over the previous 6-month period [<xref rid="pmed.1002462.ref003" ref-type="bibr">3</xref>]. HIV/AIDS has risen to feature in the top 10 causes of premature death in the RF&#x02014;a 35% increase from 2005 [<xref rid="pmed.1002462.ref004" ref-type="bibr">4</xref>]. These realities should concern all who seek global control of the HIV pandemic.</p><p>Despite the severity of this epidemic, including its scale, scope, and trajectory, remarkably little attention has been paid to the associated public health crisis in the international scientific literature. This may in part be due to the limited availability of data on HIV-1 in the RF that are presented and published outside Russia, and to the few international collaborations on HIV in the RF under the current administration. Therefore, we reviewed publicly available data in the Russian language on HIV-1 in the RF through mid-2017 and analyzed Russian federal and oblast (province)-level HIV policies and programs to assess the current burden of HIV-1 prevalence and incidence, the state of prevention programs as they relate to the epidemiology of HIV in the country, and policy impacts of current Russian laws, policies, and practices on the future trajectory of the epidemic.</p><p>Cumulative Russian federal data through mid-2017 are available on Russian language websites from several oblasts, a Federal AIDS Center report, and from <italic>Rosstat</italic>, the Russian Federal Statistics Bureau [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>,<xref rid="pmed.1002462.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pmed.1002462.ref007" ref-type="bibr">7</xref>]. Russian federal data are reported as cumulative diagnoses and as new diagnoses per 100,000 population. We used these data to generate burden maps of reported prevalence and of new diagnoses, by oblast, across the RF (<xref ref-type="fig" rid="pmed.1002462.g001">Fig 1</xref> and <xref ref-type="fig" rid="pmed.1002462.g002">Fig 2</xref>). Neither measure can be said to yield true HIV prevalence or incidence infection estimates, since they do not account for deaths (in the case of cumulative infections) or estimate the rate of new infections, including among those people never tested. Nevertheless, these available data do allow interpretation of the regional disparities and trends in Russia&#x02019;s HIV epidemic.</p><fig id="pmed.1002462.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002462.g001</object-id><label>Fig 1</label><caption><title>Cumulative HIV diagnoses in the Russian Federation in 2016 [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>,<xref rid="pmed.1002462.ref006" ref-type="bibr">6</xref>].</title><p>Labels: 1&#x02014;Republic of Adygea, 2&#x02014;Altai Krai, 3&#x02014;Amur Oblast, 4&#x02014;Arkhangelsk Oblast, 5&#x02014;Astrakhan Oblast, 6&#x02014;Republic of Bashkortostan, 7&#x02014;Belgorod Oblast, 8&#x02014;Bryansk Oblast, 9&#x02014;Republic of Buryatia, 10&#x02014;Republic of Chechnya, 11&#x02014;Chelyabinsk Oblast, 12&#x02014;Chukotka Autonomous Okrug, 13&#x02014;Chuvash Republic, 14&#x02014;City of St. Petersburg, 15&#x02014;Republic of Dagestan, 16&#x02014;Altai Republic, 17&#x02014;Republic of Ingushetia, 18&#x02014;Irkutsk Oblast, 19&#x02014;Ivanovo Oblast, 20&#x02014;Kabardino-Balkar Republic, 21&#x02014;Kaliningrad Oblast, 22&#x02014;Republic of Kalmykia, 23&#x02014;Kaluga Oblast, 24&#x02014;Kamchatka Krai, 25&#x02014;Karachay-Cherkess Republic, 26&#x02014;Republic of Karelia, 27&#x02014;Kemerovo Oblast, 28&#x02014;Khabarovsk Krai, 29&#x02014;Republic of Khakassia, 30&#x02014;Khanty-Mansiy Autonomous Okrug, 31&#x02014;Kirov Oblast, 32&#x02014;Komi Republic, 33&#x02014;Kostroma Oblast, 34&#x02014;Krasnodar Krai, 35&#x02014;Krasnoyarsk Krai, 36&#x02014;Kurgan Oblast, 37&#x02014;Kursk Oblast, 38&#x02014;Leningrad Oblast, 39&#x02014;Lipetsk Oblast, 40&#x02014;Magadan Oblast, 41&#x02014;Mariy-El Republic, 42&#x02014;Republic of Mordovia, 43&#x02014;City of Moscow, 44&#x02014;Moscow Oblast, 45&#x02014;Murmansk Oblast, 46&#x02014;Nenets Autonomous Okrug, 47&#x02014;Nizhegorod Oblast, 48&#x02014;Republic of North Ossetia-Alania, 49&#x02014;Novgorod Oblast, 50&#x02014;Novosibirsk Oblast, 51&#x02014;Omsk Oblast, 52&#x02014;Orlov Oblast, 53&#x02014;Orenburg Oblast, 54&#x02014;Penza Oblast, 55&#x02014;Perm Krai, 56&#x02014;Primorsky Krai, 57&#x02014;Pskov Oblast, 58&#x02014;Rostov Oblast, 59&#x02014;Ryazan Oblast, 60&#x02014;Sakhalin Oblast, 61&#x02014;Sakha Republic, 62&#x02014;Samara Oblast, 63&#x02014;Saratov Oblast, 64&#x02014;Smolensk Oblast, 65&#x02014;Stavropol Krai, 66&#x02014;Sverdlovsk Oblast, 67&#x02014;Tambov Oblast, 68&#x02014;Republic of Tatarstan, 69&#x02014;Tomsk Oblast, 70&#x02014;Tula Oblast, 71&#x02014;Tyva Republic, 72&#x02014;Tver Oblast, 73&#x02014;Tyumen Oblast, 74&#x02014;Republic of Udmurtia, 75&#x02014;Ulyanovsk Oblast, 76&#x02014;Vladimir Oblast, 77&#x02014;Volgograd Oblast, 78&#x02014;Vologda Oblast, 79&#x02014;Voronezh Oblast, 80&#x02014;Yamalo-Nenets Autonomous Okrug, 81&#x02014;Yaroslavl Oblast, 82&#x02014;Jewish Autonomous Oblast, 83&#x02014;Zabaykalsky Krai.</p></caption><graphic xlink:href="pmed.1002462.g001"/></fig><fig id="pmed.1002462.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002462.g002</object-id><label>Fig 2</label><caption><title>Annual new HIV diagnoses reported in 2016 per 100,000 population [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>,<xref rid="pmed.1002462.ref006" ref-type="bibr">6</xref>].</title><p>Labels: 1&#x02014;Republic of Adygea, 2&#x02014;Altai Krai, 3&#x02014;Amur Oblast, 4&#x02014;Arkhangelsk Oblast, 5&#x02014;Astrakhan Oblast, 6&#x02014;Republic of Bashkortostan, 7&#x02014;Belgorod Oblast, 8&#x02014;Bryansk Oblast, 9&#x02014;Republic of Buryatia, 10&#x02014;Republic of Chechnya, 11&#x02014;Chelyabinsk Oblast, 12&#x02014;Chukotka Autonomous Okrug, 13&#x02014;Chuvash Republic, 14&#x02014;City of St. Petersburg, 15&#x02014;Republic of Dagestan, 16&#x02014;Altai Republic, 17&#x02014;Republic of Ingushetia, 18&#x02014;Irkutsk Oblast, 19&#x02014;Ivanovo Oblast, 20&#x02014;Kabardino-Balkar Republic, 21&#x02014;Kaliningrad Oblast, 22&#x02014;Republic of Kalmykia, 23&#x02014;Kaluga Oblast, 24&#x02014;Kamchatka Krai, 25&#x02014;Karachay-Cherkess Republic, 26&#x02014;Republic of Karelia, 27&#x02014;Kemerovo Oblast, 28&#x02014;Khabarovsk Krai, 29&#x02014;Republic of Khakassia, 30&#x02014;Khanty-Mansiy Autonomous Okrug, 31&#x02014;Kirov Oblast, 32&#x02014;Komi Republic, 33&#x02014;Kostroma Oblast, 34&#x02014;Krasnodar Krai, 35&#x02014;Krasnoyarsk Krai, 36&#x02014;Kurgan Oblast, 37&#x02014;Kursk Oblast, 38&#x02014;Leningrad Oblast, 39&#x02014;Lipetsk Oblast, 40&#x02014;Magadan Oblast, 41&#x02014;Mariy-El Republic, 42&#x02014;Republic of Mordovia, 43&#x02014;City of Moscow, 44&#x02014;Moscow Oblast, 45&#x02014;Murmansk Oblast, 46&#x02014;Nenets Autonomous Okrug, 47&#x02014;Nizhegorod Oblast, 48&#x02014;Republic of North Ossetia-Alania, 49&#x02014;Novgorod Oblast, 50&#x02014;Novosibirsk Oblast, 51&#x02014;Omsk Oblast, 52&#x02014;Orlov Oblast, 53&#x02014;Orenburg Oblast, 54&#x02014;Penza Oblast, 55&#x02014;Perm Krai, 56&#x02014;Primorsky Krai, 57&#x02014;Pskov Oblast, 58&#x02014;Rostov Oblast, 59&#x02014;Ryazan Oblast, 60&#x02014;Sakhalin Oblast, 61&#x02014;Sakha Republic, 62&#x02014;Samara Oblast, 63&#x02014;Saratov Oblast, 64&#x02014;Smolensk Oblast, 65&#x02014;Stavropol Krai, 66&#x02014;Sverdlovsk Oblast, 67&#x02014;Tambov Oblast, 68&#x02014;Republic of Tatarstan, 69&#x02014;Tomsk Oblast, 70&#x02014;Tula Oblast, 71&#x02014;Tyva Republic, 72&#x02014;Tver Oblast, 73&#x02014;Tyumen Oblast, 74&#x02014;Republic of Udmurtia, 75&#x02014;Ulyanovsk Oblast, 76&#x02014;Vladimir Oblast, 77&#x02014;Volgograd Oblast, 78&#x02014;Vologda Oblast, 79&#x02014;Voronezh Oblast, 80&#x02014;Yamalo-Nenets Autonomous Okrug, 81&#x02014;Yaroslavl Oblast, 82&#x02014;Jewish Autonomous Oblast, 83&#x02014;Zabaykalsky Krai.</p></caption><graphic xlink:href="pmed.1002462.g002"/></fig><sec id="sec002"><title>The current epidemiology of HIV-1</title><p>In <xref ref-type="fig" rid="pmed.1002462.g001">Fig 1</xref>, cumulative HIV diagnoses in 2016 are shown per 100,000 population across the RF&#x02019;s subjects. <xref ref-type="fig" rid="pmed.1002462.g002">Fig 2</xref> shows annual new HIV diagnoses reported in 2016 per 100,000 population across the same territory. There is marked geographic variation in the HIV burden across the country, ranging from a high of 228.8 new diagnoses/100,000 in the Kemerovo Oblast in Southwestern Siberia to less than 5/100,000 in the southern province of Kalmykia, as well as in the Republic of Tyva bordering Mongolia. Among the 10 provinces with the greatest HIV burden in terms of new diagnoses is a geographically large cluster of 6 federal subjects in Eastern and Western Siberia (&#x0201c;federal subjects&#x0201d; is the official term referring to republics, oblasts, and cities of Federal significance in the RF). These include several provinces with contiguous borders, including Kemerovo and its neighbors Irkutsk, second most affected with 163.6/100,000 population; Tyumen, with 150.5/100,000 infections; Tomsk, with 138/100,000; Novosibirsk, with 137.1/100,000; and Krasnoyarsk with 129.5/100,000. This expansive region of 6 provinces sits north of Kazakhstan and on one of the principal overland heroin and opioid trafficking routes out of Afghanistan, the world&#x02019;s largest producer of illicit opioids in 2016 [<xref rid="pmed.1002462.ref008" ref-type="bibr">8</xref>]. Afghanistan lies to the south of the 6 federal subjects in the Siberian cluster. A second heroin and opioid trafficking route out of Afghanistan also supplies illicit opiates to the RF, this a route through the Balkans and into Southwestern Russia [<xref rid="pmed.1002462.ref008" ref-type="bibr">8</xref>].</p><p>The Siberian region also harbors the highest rates of tuberculosis (TB) infection, with incidence estimates that are 1.6 times higher than those of the rest of the country [<xref rid="pmed.1002462.ref009" ref-type="bibr">9</xref>]. Multidrug-resistant tuberculosis (MDR-TB) is also a significant public health threat in this region and in the RF more widely. People who inject drugs have been found to be the group at highest risk for acquisition of TB and MDR-TB in the RF, Belarus, and Ukraine [<xref rid="pmed.1002462.ref010" ref-type="bibr">10</xref>].</p><p>The most common risk for HIV infection across the country and in the Siberian region is exposure through sharing of injecting equipment among people who inject drugs (PWID) [<xref rid="pmed.1002462.ref001" ref-type="bibr">1</xref>,<xref rid="pmed.1002462.ref011" ref-type="bibr">11</xref>,<xref rid="pmed.1002462.ref012" ref-type="bibr">12</xref>]. In the 2016 Federal AIDS Center surveillance, PWID accounted for the largest proportion of new diagnoses of any risk group at 48.8%; followed by heterosexual sex at 48.7%; homosexual sex, reportedly 1.5%; and 0.8% among perinatally infected infants [<xref rid="pmed.1002462.ref002" ref-type="bibr">2</xref>]. These proportions are of uncertain validity, however, and confidence intervals were not reported. Adding to these uncertainties, the proportion of infections due to &#x0201c;undetermined diagnoses&#x0201d; in the data reported by Federal Scientific for the Prevention and Combat of AIDS is high and has been increasing for the past 10 years [<xref rid="pmed.1002462.ref013" ref-type="bibr">13</xref>]. In 2014, 55.4% of new infections were reported as &#x0201c;no data&#x0201d; with regards to the source of infection [<xref rid="pmed.1002462.ref013" ref-type="bibr">13</xref>]. Under-reporting of risks, especially same-sex behavior, given existing laws banning the sharing of information related to homosexuality and official allowance of stigma towards gay men and other men who have sex with men (MSM) [<xref rid="pmed.1002462.ref014" ref-type="bibr">14</xref>], is highly likely to affect these results [<xref rid="pmed.1002462.ref015" ref-type="bibr">15</xref>,<xref rid="pmed.1002462.ref016" ref-type="bibr">16</xref>].</p><p>The epidemiology of HIV in the RF after 3 decades of spread is complex and challenging to analyze. HIV burdens among MSM in the RF were reported to be in the 4%&#x02013;6% range in 2012, yet a large respondent driven sample of some 1,300 MSM in Moscow found a prevalence of 15.6% (11.6% after RDS weighting) and reported that some three-quarters of these men were not previously aware of their HIV status and had not had recent HIV testing [<xref rid="pmed.1002462.ref017" ref-type="bibr">17</xref>]. These and other studies have consistently found higher burdens of HIV infection among key populations than what has been reported in the Russian surveillance and larger numbers of key populations. This suggests that many of those most at risk for HIV are not captured in the Russian national data and that these data are likely underestimates of the true burden [<xref rid="pmed.1002462.ref018" ref-type="bibr">18</xref>]. In 2014, Pokrovskaya and colleagues from the Russian Federal AIDS Center suggested that only 51% of people living with HIV in the country in 2013 had been diagnosed with their infection [<xref rid="pmed.1002462.ref003" ref-type="bibr">3</xref>,<xref rid="pmed.1002462.ref019" ref-type="bibr">19</xref>]. If generalizable and valid, this could bring the estimated cumulative number of HIV infections in the RF to more than 2 million.</p></sec><sec id="sec003"><title>Unmet prevention needs</title><p>HIV prevention measures have lagged markedly in the RF. This has been particularly true for the large population of PWID, since evidence-based drug treatment for opioid dependence is not available [<xref rid="pmed.1002462.ref020" ref-type="bibr">20</xref>,<xref rid="pmed.1002462.ref021" ref-type="bibr">21</xref>]. The RF continues to ban any opioid agonist therapy, including prescription use of methadone and buprenorphine, despite these agents being on WHO&#x02019;s essential drug list [<xref rid="pmed.1002462.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pmed.1002462.ref023" ref-type="bibr">23</xref>].</p><p>The passage of an antigay propaganda law in 2013 further restricted an already difficult environment for gay men and other MSM in Russia, also reducing prevention and treatment access for these men [<xref rid="pmed.1002462.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pmed.1002462.ref017" ref-type="bibr">17</xref>]. After passage of the 2013 law, it became illegal to post or discuss information for gay men and other MSM, even on informational websites in Russia, further restricting information. Preexposure prophylaxis is not available, and treatment coverage for MSM is remarkably low, even in Moscow, where only some 9% of MSM living with HIV infection were found to be on antiretroviral therapy in 2014 [<xref rid="pmed.1002462.ref017" ref-type="bibr">17</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec004"><title>Conclusions</title><p>The RF is undergoing a severe, widespread, and geographically dispersed HIV epidemic. There is a very large 6-region cluster in Eastern and Western Siberia that is now the most affected part of this vast country. HIV prevalence and incidence are difficult to directly deduce from the available reporting data, but there is enough evidence to suggest that Russia&#x02019;s epidemic is uncontrolled and worsening in 2017. It is disturbing that deaths are rising rapidly in an upper middle-income country that could, and should, be doing much better in the provision of prevention, treatment, care, and support for its citizens, especially those at high risk of HIV infection [<xref rid="pmed.1002462.ref024" ref-type="bibr">24</xref>].</p><p>The continuous growth of the Russian HIV epidemic is a failure of public policy and practice. The current list of interventions with demonstrable efficacy in reducing HIV spread and improving treatment outcomes includes opioid agonist substitution therapy, needle and syringe exchanges, treatment as prevention, preexposure prophylaxis, and tailored interventions for key populations including PWID, MSM, sex workers, prisoners, and migrants. In the RF, all of these interventions are either not available or are unavailable at the scale necessary to control HIV. This is a true public health crisis and one that could largely have been avoided. Unless evidence-based prevention measures aimed at the most at-risk population groups are brought to scale in the RF, and unless access to treatment is significantly increased for all HIV-infected people, the likelihood of greater HIV incidence, and consequently greater AIDS morbidity and mortality, will only increase.</p></sec></body><back><ack><p><bold>Disclaimer:</bold> This content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p></ack><fn-group><fn fn-type="other" id="fn001"><p><bold>Provenance:</bold> Commissioned; not externally peer reviewed</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>ECDC</term><def><p>European Centre for Disease Prevention and Control</p></def></def-item><def-item><term>MDR-TB</term><def><p>multidrug-resistant tuberculosis</p></def></def-item><def-item><term>MSM</term><def><p>men who have sex with men</p></def></def-item><def-item><term>PWID</term><def><p>people who inject drugs</p></def></def-item><def-item><term>RF</term><def><p>Russian Federation</p></def></def-item><def-item><term>TB</term><def><p>tuberculosis</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pmed.1002462.ref001"><label>1</label><mixed-citation publication-type="other">UNAIDS. Gap Report. Geneva: UNAIDS, 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf">http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf</ext-link></mixed-citation></ref><ref id="pmed.1002462.ref002"><label>2</label><mixed-citation publication-type="other">Federal Scientific for the Prevention and Combat of AIDS of the Public Office of the Central Scientific Research Institute Rospotrebnadzor. Spravka, VICH infektsiya v Rossiiskoi Federatsiy na 30 iyunia 2016 goda&#x0201d;. &#x0201c;&#x00421;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043a;&#x00430;, &#x00412;&#x00418;&#x00427;-&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0044f; &#x00432; &#x00420;&#x0043e;&#x00441;&#x00441;&#x00438;&#x00439;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00424;&#x00435;&#x00434;&#x00435;&#x00440;&#x00430;&#x00446;&#x00438;&#x00438; &#x0043d;&#x00430; 30 &#x00438;&#x0044e;&#x0043d;&#x0044f; 2016 &#x00433;. &#x0201c;Reference on HIV infection in the Russian Federation as of June 30, 2016&#x0201d;.: Perm Krai Public Health Office, Perm Krai Center for the Prevention and Combat of AIDS and Infectious Diseases 2016.</mixed-citation></ref><ref id="pmed.1002462.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Pokrovsky</surname><given-names>VV</given-names></name>, <name><surname>Ladnaia</surname><given-names>N</given-names></name>, <name><surname>Pokrovskaya</surname><given-names>A</given-names></name>. <article-title>HIV/AIDS reduces the number of Russians and their life expectancy</article-title>. <source>Demographic Review</source>
<year>2017</year>; (<issue>1</issue>): <fpage>65</fpage>&#x02013;<lpage>82</lpage>.</mixed-citation></ref><ref id="pmed.1002462.ref004"><label>4</label><mixed-citation publication-type="book"><collab>IHME</collab>. <source>Global Burden of Disease Profile</source>: <publisher-loc>Russia. Seattle</publisher-loc>: <publisher-name>Institute for Health Metrics and Evaluation</publisher-name>, <year>2013</year>.</mixed-citation></ref><ref id="pmed.1002462.ref005"><label>5</label><mixed-citation publication-type="other">&#x00420;&#x00415;&#x00413;&#x00418;&#x0041e;&#x0041d;&#x0042b; &#x00420;&#x0041e;&#x00421;&#x00421;&#x00418;&#x00418; &#x00421;&#x0041e;&#x00426;&#x00418;&#x00410;&#x0041b;&#x0042c;&#x0041d;&#x0041e;-&#x0042d;&#x0041a;&#x0041e;&#x0041d;&#x0041e;&#x0041c;&#x00418;&#x00427;&#x00415;&#x00421;&#x0041a;&#x00418;&#x00415; &#x0041f;&#x0041e;&#x0041a;&#x00410;&#x00417;&#x00410;&#x00422;&#x00415;&#x0041b;&#x00418; 2016 &#x00421;&#x00422;&#x00410;&#x00422;&#x00418;&#x00421;&#x00422;&#x00418;&#x00427;&#x00415;&#x00421;&#x0041a;&#x00418;&#x00419; &#x00421;&#x00411;&#x0041e;&#x00420;&#x0041d;&#x00418;&#x0041a; (2016 report on Socio-economic indicators in Regions by the Department of official statistics of the Russian Federation [Rosstat]). Moscow: Rosstat, 2016.</mixed-citation></ref><ref id="pmed.1002462.ref006"><label>6</label><mixed-citation publication-type="other">Federal Scientific for the Prevention and Combat of AIDS of the Public Office of the Central Scientific Research Institute Rospotrebnadzor. &#x0041f;&#x0043e;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043d;&#x00438;&#x00435; &#x0044d;&#x0043f;&#x00438;&#x00434;&#x00435;&#x0043c;&#x00438;&#x0043e;&#x0043b;&#x0043e;&#x00433;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e; &#x00412;&#x00418;&#x00427;-&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x00438; &#x00432; &#x00420;&#x0043e;&#x00441;&#x00441;&#x00438;&#x00439;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00424;&#x00435;&#x00434;&#x00435;&#x00440;&#x00430;&#x00446;&#x00438;&#x00438; (The latest epidemiological data on HIV in the Russian Federation). 2017. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.hivrussia.ru/stat/bulletin.shtml#40">http://www.hivrussia.ru/stat/bulletin.shtml#40</ext-link> (accessed 01 Aug 2017).</mixed-citation></ref><ref id="pmed.1002462.ref007"><label>7</label><mixed-citation publication-type="other">European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2015 surveillance report. Stockholm: ECDC, 2016.</mixed-citation></ref><ref id="pmed.1002462.ref008"><label>8</label><mixed-citation publication-type="other">United Nations Office on Drugs and Crime. World Drug Report. New York, 2017.</mixed-citation></ref><ref id="pmed.1002462.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Keshavjee</surname><given-names>S</given-names></name>, <name><surname>Sweeney</surname><given-names>C</given-names></name>, <name><surname>Yedilbayev</surname><given-names>A</given-names></name>, <name><surname>Taran</surname><given-names>D</given-names></name>, <name><surname>Solovyova</surname><given-names>A</given-names></name>, <name><surname>Gelmanova</surname><given-names>I</given-names></name>. <article-title>The Sputnik Initiative: Patient-centered accompaniment for Tuberculosis in Russia</article-title>: <source>Partners in Health</source>, <year>2014</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.pih.org/practitioner-resource/the-sputnik-initiative-patient-centered-accompaniment-for-tuberculosis-in-r">https://www.pih.org/practitioner-resource/the-sputnik-initiative-patient-centered-accompaniment-for-tuberculosis-in-r</ext-link></mixed-citation></ref><ref id="pmed.1002462.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Post</surname><given-names>FA</given-names></name>, <name><surname>Grint</surname><given-names>D</given-names></name>, <name><surname>Werlinrud</surname><given-names>AM</given-names></name>, <name><surname>Panteleev</surname><given-names>A</given-names></name>, <name><surname>Riekstina</surname><given-names>V</given-names></name>, <name><surname>Malashenkov</surname><given-names>EA</given-names></name>, <etal>et al</etal>
<article-title>Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe</article-title>. <source>J Infect</source>
<year>2014</year>; <volume>68</volume>(<issue>3</issue>): <fpage>259</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jinf.2013.09.034">10.1016/j.jinf.2013.09.034</ext-link></comment>
<?supplied-pmid 24247067?><pub-id pub-id-type="pmid">24247067</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Gashnikova</surname><given-names>NM</given-names></name>, <name><surname>Astakhova</surname><given-names>EM</given-names></name>, <name><surname>Gashnikova</surname><given-names>MP</given-names></name>, <name><surname>Bocharov</surname><given-names>EF</given-names></name>, <name><surname>Petrova</surname><given-names>SV</given-names></name>, <name><surname>Pun'ko</surname><given-names>OA</given-names></name>, <etal>et al</etal>
<article-title>HIV-1 Epidemiology, Genetic Diversity, and Primary Drug Resistance in the Tyumen Oblast, Russia</article-title>. <source>Biomed Res Int</source>
<year>2016</year>; <volume>2016</volume>: <fpage>2496280</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2016/2496280">10.1155/2016/2496280</ext-link></comment>
<?supplied-pmid 27957489?><pub-id pub-id-type="pmid">27957489</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Dovgopolyuk</surname><given-names>ES</given-names></name>, <name><surname>Puzyreva</surname><given-names>LV</given-names></name>, <name><surname>Safonov</surname><given-names>AD</given-names></name>, <name><surname>Mordyk</surname><given-names>AV</given-names></name>, <name><surname>Tyumentsev</surname><given-names>AT</given-names></name>, <name><surname>Levakhina</surname><given-names>LI</given-names></name>, <etal>et al</etal>
<article-title>(Epidemic Situation For HIV-Infection In Siberian Federal Region In 2014)</article-title>. <source>Zhurnal mikrobiologii, epidemiologii, i immunobiologii</source>
<year>2016</year>; (2): <fpage>37</fpage>&#x02013;<lpage>41</lpage>. <?supplied-pmid 27228669?><pub-id pub-id-type="pmid">27228669</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref013"><label>13</label><mixed-citation publication-type="other">Federal Scientific for the Prevention and Combat of AIDS of the Public Office of the Central Scientific Research Institute Rospotrebnadzor. &#x00412;&#x00418;&#x00427;-&#x00418;&#x0041d;&#x00424;&#x00415;&#x0041a;&#x00426;&#x00418;&#x0042f; &#x00418;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x00439; &#x00431;&#x0044e;&#x0043b;&#x0043b;&#x00435;&#x00442;&#x00435;&#x0043d;&#x0044c; &#x02116; 40 (HIV Infection Bulletin &#x02116; 40). Moscow, 2015.</mixed-citation></ref><ref id="pmed.1002462.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Elder</surname><given-names>M</given-names></name>. <article-title>Russia passes law banning gay 'propaganda'</article-title>. <source>The Guardian</source>. <year>2013</year>
<day>11</day>
<month>6</month>.</mixed-citation></ref><ref id="pmed.1002462.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Wirtz</surname><given-names>AL</given-names></name>, <name><surname>Zelaya</surname><given-names>CE</given-names></name>, <name><surname>Peryshkina</surname><given-names>A</given-names></name>, <name><surname>Latkin</surname><given-names>C</given-names></name>, <name><surname>Mogilnyi</surname><given-names>V</given-names></name>, <name><surname>Galai</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: implications for prevention</article-title>. <source>AIDS Care</source>
<year>2014</year>; <volume>26</volume>(<issue>3</issue>): <fpage>387</fpage>&#x02013;<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/09540121.2013.819407">10.1080/09540121.2013.819407</ext-link></comment>
<?supplied-pmid 23875610?><pub-id pub-id-type="pmid">23875610</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Hylton</surname><given-names>E</given-names></name>, <name><surname>Wirtz</surname><given-names>AL</given-names></name>, <name><surname>Zelaya</surname><given-names>CE</given-names></name>, <name><surname>Latkin</surname><given-names>C</given-names></name>, <name><surname>Peryshkina</surname><given-names>A</given-names></name>, <name><surname>Mogilnyi</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Sexual Identity, Stigma, and Depression: the Role of the "Anti-gay Propaganda Law" in Mental Health among Men Who Have Sex with Men in Moscow, Russia</article-title>. <source>J Urban Health</source>
<year>2017</year>; <volume>94</volume>(<issue>3</issue>): <fpage>319</fpage>&#x02013;<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11524-017-0133-6">10.1007/s11524-017-0133-6</ext-link></comment>
<?supplied-pmid 28243868?><pub-id pub-id-type="pmid">28243868</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Wirtz</surname><given-names>AL</given-names></name>, <name><surname>Zelaya</surname><given-names>CE</given-names></name>, <name><surname>Latkin</surname><given-names>C</given-names></name>, <name><surname>Peryshkina</surname><given-names>A</given-names></name>, <name><surname>Galai</surname><given-names>N</given-names></name>, <name><surname>Mogilnyi</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>The HIV care continuum among men who have sex with men in Moscow, Russia: a cross-sectional study of infection awareness and engagement in care</article-title>. <source>Sex Transm Infect. 2016</source>; <volume>92</volume>(<issue>2</issue>): <fpage>161</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/sextrans-2015-052076">10.1136/sextrans-2015-052076</ext-link></comment>
<?supplied-pmid 26297721?><pub-id pub-id-type="pmid">26297721</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref018"><label>18</label><mixed-citation publication-type="book"><name><surname>Platt</surname><given-names>L</given-names></name>, <name><surname>Jolley</surname><given-names>E</given-names></name>, <name><surname>Hope</surname><given-names>V</given-names></name>, <name><surname>Latypov</surname><given-names>A</given-names></name>, <name><surname>Vickerman</surname><given-names>P</given-names></name>, <name><surname>Hickson</surname><given-names>F</given-names></name>, <etal>et al</etal>
<source>HIV in the European Region: Vulnerability and Response</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The World Bank</publisher-name>, <year>2013</year>
<ext-link ext-link-type="uri" xlink:href="https://openknowledge.worldbank.org/handle/10986/21361">https://openknowledge.worldbank.org/handle/10986/21361</ext-link> L</mixed-citation></ref><ref id="pmed.1002462.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Pokrovskaya</surname><given-names>A</given-names></name>, <name><surname>Popova</surname><given-names>A</given-names></name>, <name><surname>Ladnaya</surname><given-names>N</given-names></name>, <name><surname>Yurin</surname><given-names>O</given-names></name>. <article-title>The cascade of HIV care in Russia, 2011&#x02013;2013</article-title>. <source>J Int AIDS Soc</source>
<year>2014</year>; <volume>17</volume>(<issue>4</issue> Suppl 3): <fpage>19506</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7448/IAS.17.4.19506">10.7448/IAS.17.4.19506</ext-link></comment>
<?supplied-pmid 25394015?><pub-id pub-id-type="pmid">25394015</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Csete</surname><given-names>J</given-names></name>, <name><surname>Kamarulzaman</surname><given-names>A</given-names></name>, <name><surname>Kazatchkine</surname><given-names>M</given-names></name>, <name><surname>Altice</surname><given-names>F</given-names></name>, <name><surname>Balicki</surname><given-names>M</given-names></name>, <name><surname>Buxton</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Public health and international drug policy</article-title>. <source>Lancet</source>
<year>2016</year>; <volume>387</volume>(<issue>10026</issue>): <fpage>1427</fpage>&#x02013;<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(16)00619-X">10.1016/S0140-6736(16)00619-X</ext-link></comment>
<?supplied-pmid 27021149?><pub-id pub-id-type="pmid">27021149</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Degenhardt</surname><given-names>L</given-names></name>, <name><surname>Mathers</surname><given-names>BM</given-names></name>, <name><surname>Wirtz</surname><given-names>AL</given-names></name>, <name><surname>Wolfe</surname><given-names>D</given-names></name>, <name><surname>Kamarulzaman</surname><given-names>A</given-names></name>, <name><surname>Carrieri</surname><given-names>MP</given-names></name>, <etal>et al</etal>
<article-title>What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010&#x02013;2012? A review of the six highest burden countries</article-title>. <source>Int J Drug Policy</source>
<year>2014</year>; <volume>25</volume>(<issue>1</issue>): <fpage>53</fpage>&#x02013;<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.drugpo.2013.08.004">10.1016/j.drugpo.2013.08.004</ext-link></comment>
<?supplied-pmid 24113623?><pub-id pub-id-type="pmid">24113623</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Beyrer</surname><given-names>C</given-names></name>, <name><surname>Malinowska-Sempruch</surname><given-names>K</given-names></name>, <name><surname>Kamarulzaman</surname><given-names>A</given-names></name>, <name><surname>Kazatchkine</surname><given-names>M</given-names></name>, <name><surname>Sidibe</surname><given-names>M</given-names></name>, <name><surname>Strathdee</surname><given-names>SA</given-names></name>. <article-title>Time to act: a call for comprehensive responses to HIV in people who use drugs</article-title>. <source>Lancet</source>
<year>2010</year>; <volume>376</volume>(<issue>9740</issue>): <fpage>551</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(10)60928-2">10.1016/S0140-6736(10)60928-2</ext-link></comment>
<?supplied-pmid 20650515?><pub-id pub-id-type="pmid">20650515</pub-id></mixed-citation></ref><ref id="pmed.1002462.ref023"><label>23</label><mixed-citation publication-type="book"><publisher-name>World Health Organization</publisher-name>
<source>Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2014</year>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/guidelines/keypopulations/en/">http://www.who.int/hiv/pub/guidelines/keypopulations/en/</ext-link></mixed-citation></ref><ref id="pmed.1002462.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>F</given-names></name>. <article-title>Gaps remain in Russia's response to HIV/AIDS</article-title>. <source>Lancet</source>
<year>2016</year>; <volume>388</volume>(<issue>10047</issue>): <fpage>857</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(16)31480-5">10.1016/S0140-6736(16)31480-5</ext-link></comment>
<?supplied-pmid 27597456?><pub-id pub-id-type="pmid">27597456</pub-id></mixed-citation></ref></ref-list></back></article>